V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10369572 | 10040167 | 0 | 45 | Curative (C) | 2020-02-17 | 2020-02-17 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100323856 |
| 10369603 | 10040168 | 1.67 | 80.3 | Adjuvant (A) | 2019-10-16 | 2019-11-02 | CVP R | N | N | DARATUMUMAB | 101257444 |
| 10369616 | 10040169 | 1.52 | 71 | Curative (C) | 2021-11-04 | 2021-11-20 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | BUSULFAN | 100867599 |
| 10369619 | 10040170 | 1.86 | 82.8 | null | 2022-05-10 | 2022-05-12 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101494828 |
| 10369643 | 10040173 | null | 89.1 | Adjuvant (A) | 2019-10-16 | 2019-10-16 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100937751 |
| 10369662 | 10040174 | 1.61 | 60 | Palliative (P) | 2017-07-09 | 2017-07-13 | R GCVP | 02 | N | DABRAFENIB + TRAMETINIB | 100142520 |
| 10369766 | 10040175 | 1.63 | 76 | null | 2021-08-18 | 2021-08-29 | FEC 100 + DOCETAXEL | 02 | N | DABRAFENIB + TRAMETINIB | 100984419 |
| 10369772 | 10040176 | 1.7 | 95.5 | null | 2019-08-04 | 2019-08-19 | Avelumab | 02 | null | AVELUMAB | 101169015 |
| 10369779 | 10040177 | 1.79 | 59.2 | Curative (C) | 2018-12-20 | 2018-12-21 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101661212 |
| 10369838 | 10040178 | 1.56 | 75.3 | Palliative (P) | 2019-05-22 | 2019-05-29 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 100366904 |
| 10369898 | 10040179 | 1.75 | 57.15 | 03 | 2017-07-12 | 2017-07-12 | IPILIMUMAB + NIVOLUMAB | N | N | IPILIMUMAB + NIVOLUMAB | 100189013 |
| 10369910 | 10040180 | 1.64 | 72.4 | null | 2016-10-13 | 2016-12-29 | FLUOROURACIL + IRINOTECAN | 02 | Y | FLUOROURACIL + IRINOTECAN | 101524358 |
| 10370134 | 10040183 | 1.8 | 95 | Palliative (P) | 2018-04-17 | 2018-04-30 | DABRAFENIB + TRAMETINIB | N | N | BCG | 100922700 |
| 10370151 | 10040184 | 1.76 | 89 | null | 2018-01-10 | 2018-01-10 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 100082446 |
| 10370237 | 10040187 | 1.72 | 71 | Palliative (P) | 2019-01-24 | 2019-01-24 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 100299104 |
| 10370277 | 10040188 | 1.67 | 61.1 | Palliative (P) | 2018-03-31 | 2018-05-01 | NIVOLUMAB | N | null | NIVOLUMAB | 100290132 |
| 10370373 | 10040189 | 1.61 | 77.1 | Palliative (P) | 2017-10-29 | 2017-10-30 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 100328934 |
| 10370417 | 10040190 | 1.81 | 97.8 | Palliative (P) | 2019-11-20 | 2019-11-22 | DABRAFENIB + TRAMETINIB | N | N | CLADRIBINE | 100486495 |
| 10370462 | 10040191 | 1.62 | 57 | null | 2016-12-19 | 2017-01-02 | CYTARABINE | 02 | null | CISPLATIN + VINORELBINE | 101242632 |
| 10370515 | 10040192 | 1.53 | 98.3 | Palliative (P) | 2018-10-19 | 2018-11-24 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 101859752 |
| 10370593 | 10040193 | 1.55 | 85 | 03 | 2016-08-09 | 2016-08-09 | Palbociclib | 02 | N | PALBOCICLIB | 101250125 |
| 10370611 | 10040194 | 1.68 | 82.4 | null | 2019-05-01 | 2019-05-01 | Pazopanib | 02 | null | CVP R | 100966611 |
| 10370656 | 10040195 | 0 | 0 | Curative (C) | 2021-01-16 | 2021-01-16 | CHOP R | 01 | N | CHOP R | 101836863 |
| 10370696 | 10040196 | 1.72 | 68.8 | 03 | 2018-08-14 | 2018-08-23 | CHOP R + Prednisolone | 02 | N | CHOP R | 100638657 |
| 10370826 | 10040198 | 1.67 | 55 | Palliative (P) | 2019-08-26 | 2019-08-26 | CHLORAMBUCIL + RITUXIMAB | 02 | Y | CHLORAMBUCIL + RITUXIMAB | 100415103 |
| 10370832 | 10040199 | 1.8 | 69.3 | Disease modification (D) | 2019-06-01 | 2019-06-11 | POMALIDOMIDE | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101709998 |
| 10370907 | 10040200 | 0 | 0 | Disease modification (D) | 2018-05-27 | 2018-06-03 | Capecitabine + Cisplatin | 02 | N | SUNITINIB | 100325381 |
| 10370954 | 10040202 | null | 0 | null | 2019-09-08 | 2019-09-14 | Venetoclax | 99 | N | DARATUMUMAB | 100383388 |
| 10370993 | 10040203 | 1.68 | null | Curative (C) | 2017-10-27 | 2017-10-27 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101817954 |
| 10371021 | 10040206 | 1.8 | 77.2 | null | 2020-06-17 | 2020-06-17 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CAPECITABINE + GEMCITABINE | 100608249 |
| 10371080 | 10040208 | 1.63 | 70 | Adjuvant (A) | 2016-08-02 | 2018-09-01 | BCG Intravesical | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100708211 |
| 10371112 | 10040209 | 1.68 | 108.3 | Disease modification (D) | 2018-07-31 | 2018-08-01 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101010777 |
| 10371291 | 10040212 | null | 70.75 | Adjuvant (A) | 2017-03-01 | 2017-03-02 | FLUOROURACIL | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101470352 |
| 10371320 | 10040213 | 1.56 | 73.4 | Palliative (P) | 2016-12-15 | 2017-06-12 | Folfirinox/ Folfoxiri | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100318624 |
| 10371333 | 10040214 | 1.62 | 89.5 | Palliative (P) | 2019-10-23 | 2019-10-31 | CHOP R - 21 days | 02 | N | CHOP R | 101245681 |
| 10371439 | 10040216 | 1.65 | 75 | Palliative (P) | null | 2016-10-29 | DABRAFENIB + TRAMETINIB | 02 | N | VENETOCLAX | 101008101 |
| 10371467 | 10040217 | null | null | null | 2019-08-08 | 2019-08-09 | MITOMYCIN | 02 | null | DABRAFENIB + TRAMETINIB | 101067732 |
| 10371607 | 10040222 | 1.62 | 66.5 | null | 2019-05-02 | 2019-05-30 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 100704184 |
| 10371665 | 10040224 | 1.8 | 113.2 | Curative (C) | 2018-08-03 | 2018-08-03 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100496834 |
| 10371740 | 10040227 | 1.62 | null | null | 2022-04-24 | 2022-04-26 | CHOP R | 02 | null | CHOP R | 100910530 |
| 10371778 | 10040229 | 1.68 | 90 | Adjuvant (A) | 2019-03-18 | 2019-04-06 | Bortezomib (weekly) | N | N | BORTEZOMIB | 101048171 |
| 10371784 | 10040230 | 1.67 | null | Adjuvant (A) | 2017-03-10 | 2017-03-21 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100896984 |
| 10371922 | 10040232 | 1.68 | 86 | Palliative (P) | 2016-07-31 | 2016-08-15 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100777719 |
| 10371951 | 10040233 | 1.61 | 83 | null | 2019-12-10 | 2020-01-28 | Capecitabine + Cisplatin + RT | 02 | null | SUNITINIB | 100237364 |
| 10372076 | 10040234 | 1.52 | 102.6 | Adjuvant (A) | 2019-08-08 | 2019-08-29 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101552053 |
| 10372131 | 10040235 | 0 | 0 | null | 2018-05-23 | 2018-05-23 | Cyclophosphamide + Docetaxel | 02 | null | CISPLATIN + FLUOROURACIL | 101569621 |
| 10372166 | 10040236 | 0 | 0 | Palliative (P) | null | 2019-08-17 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101476097 |
| 10372190 | 10040237 | 1.72 | 76.9 | 03 | 2018-11-10 | 2018-11-13 | Trial Unspecified | 02 | N | CISPLATIN + FLUOROURACIL | 100812304 |
| 10372214 | 10040238 | 0 | 0 | Palliative (P) | 2019-08-18 | 2019-08-23 | Palbociclib | 02 | N | PALBOCICLIB | 101566347 |
| 10372243 | 10040239 | 0 | 0 | 02 | 2021-10-29 | 2021-11-17 | DABRAFENIB + TRAMETINIB | 02 | N | FLUOROURACIL | 100069580 |